Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Central Clinic

Journal
Presentation
    （Last updated : 2022-07-02 10:28:47）
  Yokoyama Yoko
   Department   Specialty Division  , Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis. 2013/04
2. Original article　 Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA. 2013/05
3. Original article　 Questionnaire based assessment of patients' acceptability of leukocytapheresis for the treatment of inflammatory bowel disease. 2013/10
4. Original article　 Prospective postsurgical capsule endoscopy in patients with Crohn's disease 2014/03
5. Original article　 Crohn's disease complicated by hepatitis B virus successfully treated with the use of adsorptive depletion of myeloid lineage leucocytes to suppress inflammatory cytokine profile. 2014/06
6. Original article　 A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice. 2014/09
7. Original article　 A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis. 2014/09
8. Original article　 An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease. 2015
9. Case report　 Surgery for severe ulcerative colitis during pregnancy: Report of Two cases. 2015/03
10. Original article　 Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study. 2015/05
11. Original article　 Granulomonocytapheresis as a cell-based therapy in an ulcerative colitis patient complicated by aminosalicylate-induced severe lymphocytopenia and pneumonia. 2016/09
12. Original article　 NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases. 2017/07
13. Original article　 Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte/monocyte apheresis: A case series. 2017/12
14. Original article　 Correction to: Management of elderly ulcerative colitis in Japan. 2019/07 Link
15. Original article　 Correction to: Management of elderly ulcerative colitis in Japan. 2019/10 Link
Display 5 items
Display all(15)
■ Presentation
1. Capsule endoscopy for assessing small bowel residual lesions at resection and postsurgical recurrence in Crohn's disease  2012/12
2. Clinical features of bamboo joint like appearance at the gastric body and cardia,notches in the duodenum with crohn,s disease  2013/01/26
3. Association between autoantibodies against the gastric proliferative zone and inflammatory bowel disease  2013/02/15
4. Effectiveness of a new type ultrathin colonoscope in colonoscopy of patients with active ulcerative colitis  2013/02/15
5. Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis  2013/02/15
6. Predictive factors of refractory to tacrolimus therapy in patients with active ulcerative colitis  2013/02/15
7. A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury in subjects taking low-dose aspirin with or without clopidogrel  2013/05/18
8. Effectiveness of a new type ultrathin colonoscope in colonoscopy of patients with active ulcerative colitis  2013/05/18
9. IBS-like symptoms in Japanese patients with inactive inflammatory bowel disease is associated with decreased quality of life  2013/05/20
10. The predictive factors for refractory status and readmission after tacrolimus treatment in patients with active ulcerative colitis  2013/05/21
11. Efficacy of infliximab in pediatric crohn's disease patinets.  2013/06/13
12. The Processed Blood Volume per Body Weight for Granulocyte and Monocytes Adsorption Session in Patients with Crohn,s Disease  2013/10/16
13. A report on the prevalence and reactivation rate of hepatitis B virus in patients with inflammatory bowel disease in Japan  2014/02/21
14. α Infliximab remission induction therapy in patients with ulcerative colitis: Does tumour necrosis factor- α receptor blockade per se explain its multiple actions?  2014/02/21
15. A report on the prevalence and reactivation rate of hepatitis b virus in patients with inflammatory bowel disease in Japan  2014/05/03
16. Predictore of Long-term Prognosis in Patients with Ulcerative Colitis after Remission Induction by Adsorptive Granulocyte/Monocyte Apheresis:A Prospecitive Study Involving 32 Centers  2014/06/20
17. Factors Associated With Treatment Outcome,and Long-Term Prognosis of Patients With Ulcerative Colitis Undergoing Adsorptive Granulocyte/Monocyte Apheresis: A Prospective Multicentre Investigation  2015/05/16
18. Incidence and Severity of Acute Kidney Injury During Oral Tacrolimus Treatment in Patients With Refractory Ulcerative Colitis  2015/05/16
19. The Outcome of 142 Endoscopic Balloon Dilatations of Ileocaecal and Colonic Strictures in Patients With Crohn's Disease Patients  2015/05/16
20. Disease Extension in Japanese Patients With Ulcerative Colitis and the Clinical Course  2015/06/19
21. THE CLINICAL OUTCOMES OF 165 ENDOSCOPIC BALLOON DILATATION FOR ILEOCOLONIC OR CAECAL STRICTURES IN PATIENTS WITH CROHN'S DISEASE  2015/10/28
22. Long term efficacy and safety of thiopurines in patients with steroid dependent Ulcerative Colitis: A retrospective investigation  2016/03/18
23. Pregnancy outcomes in patients with Inflammatory Bowel Disease experiencing flare ups during foetal development  2016/03/18
24. Proximal extension of distal lesions in patients with Ulcerative Colitis  2016/03/18
25. The efficacy of infliximab in tacrolomus non-responder with UC  2016/03/18
26. Pregnancy Outcomes in Patients with Inflammatory Bowel Disease Experiencing Flare ups During Foetal Development  2016/05/22
27. Factors Associated With Restenosis and the Need for Surgical Interventions in Patients With Crohn`s Disease Undergoing Endoscopic Balloon Dilatation for Lower Gastrointestinal Strictures  2016/05/23
28. Long Term Efficacy and Safety of Thiopurines in Patients With Steroid Dependent Ulcerative Colitis: A Retrospective Investigation  2016/05/23
29. The endoscopic feature of relapse in ulcerative colitis treated with infliximab.  2016/07/08
30. Genetically-Determined Increases in LRRK2 Levels enhance susceptibility to colitis  2016/07/09
31. Pregnancy complications and outcomes in patients with Inflammatory Bowel Disease  2017/02/17
32. Efficacy of Adsorptive Granulocyte/Monocyte Apheresis in Inflammatory Bowel Disease Patients Experiencing Loss of Response to Infliximab:A Case Series.  2017/06/17
33. Thiopurine-induced Leukopenia Is Associated with a Variant in NUDT15, but Not FTO and RUNX1 in Japanese Patients with Inflammatory Bowel Diseases.  2017/06/17
34. LRRK2 Inhibitor Attenuates Intestinal Inflammation and Becomes a Therapeutic Strategy in Inflammatory Bowel Diseases  2017/07/21
35. Clinical and endoscopic features of secondary loss of response caases in patients with Crohns disease treated with infliximab by top down strategy a case control study  2018/02/16
36. Clinical characteristics and complications in hospitalised elderly patients with ulcerative colitis in a real world specialised hospital  2018/02/16
37. CLINICAL CHARACTERISTICS AND COMPLICATIONS IN HOSPITALISED ELDERLY PATIENTS WITH ULCERATIVE COLITIS IN A REAL-WORLD SPECIALISED HOSPITAL  2018/06/04
38. THE INITIAL TROUGH CONCENRTATION AT 36 HOURS AFTER STARTING TACROLIMUS IS IMPORTANT FOR THE PERSONALIZED MEDICINE STRATEGY IN PATIENTS WITH ULCERATIVE COLITIS  2018/06/04
39. Clinical features of ulcerative colitis complicated by autoimmune hepatitis: a case series in Japan  2018/06/22
40. Efficacy and related issues of cytapheresis in elderly patients with ulcerative colitis  2018/06/22
41. Endoscopic features for loss of response in patients with Crohn’s disease who were treated with infliximab by top-down strategy.  2019/03/08
42. Investigations of the characteristics and efficary of anti-TNFα agents for optimizing treatment in pediatric patients with new-onset Crhon’s disease.  2019/03/08
43. Risk factors and clinical characteristics for Pneumonia in Japanese Patients with Ulcerative Colitis.  2019/03/08
44. The initial trough concentration at 36 hours after starting tacrolimus is important for the personalized medicine strategy in patients with ulcerative colitis.  2019/03/08
45. CLINICAL CHARACTERISTICS AND RISK FACTORS FOR PNEUMOCYSTIS JIROVECII PNEUMONIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.  2019/05/19
46. Investigations of the characteristics and anti-TNFα agents for optimizing treatment in pediatric patients with new-onset Crohn’s disease.  2019/05/19
47. The apheresis guidelines for digestive diseases  2019/10/19
48. Real-world experience of cytapheresis therapy for ulcerative colitis; results from large-scale multicenter observational studies  2019/11/19
49. Investigations of the characteristics and efficacy of anti-TNFα agents for optimizing treatment in pediatric patients with new-onset Crohn’s disease.  2019/11/21
50. EFFICACY AND SAFETY OF TOFACITINIB TREATMENT FOR 1 YEAR IN JAPANESE PATIENTS WITH ULCERATIVE COLITIS IN A SPECIALIZED IBD CENTER.  2021/05/22
51. Efficacy and safety of tofacitinib treatment for one year in Japanese patients with Ulcerative Colitis in a specialized Inflammatory Bowel Disease center.  2021/07/08
52. EFFICACY AND SAFETY OF TOFACITINIB TREATMENT FOR 1 YEAR IN PATIENTS WITH ULCERATIVE COLITIS IN A SPECIALIZED IBD CENTER.  2021/11/13
Display 5 items
Display all(52)
mail